Population Pharmacokinetics of Rifabutin in Human Immunodeficiency Virus-Infected Patients

Rifabutin pharmacokinetics were studied by the population approach (NONMEM) with 40 human immunodeficiency virus-infected patients receiving rifabutin at different doses for prophylaxis or therapy of mycobacterial infections. A two-compartment open model with first-order absorption was used as the s...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Gatti, Giorgio, Papa, Pietro, Torre, Donato, Andreoni, Massimo, Poggio, Antonio, Bassetti, Matteo, Marone, Piero
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1998
Schlagworte:	Pharmacology
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105726/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9687400/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.8.2017
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!